Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and

Richard Sedrani1, Jörg Kallen, Luisa M Martin Cabrejas

  • 1Transplantation Research, Novartis Pharma AG, S-507.312, CH-4002 Basel, Switzerland.